medigraphic.com
SPANISH

MediSan

ISSN 1029-3019 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 10

<< Back Next >>

MediSan 2013; 17 (10)

Risk of pulmonary embolism and prophylactic treatment in critically ill patients admitted to an intermediate care unit

Oliva CL, Vila BJ, Peña OS, Arce FN
Full text How to cite this article

Language: Spanish
References: 15
Page: 6063-6070
PDF size: 150.51 Kb.


Key words:

pulmonary embolism, risk factor, prophylactic treatment, Intermediate Care Unit, secondary health care.

ABSTRACT

A descriptive, cross-sectional and prospective study of 96 patients, admitted to the Intermediate Care Unit of "Dr. Joaquín Castillo Duany" Teaching Clinical Surgical Hospital in Santiago de Cuba was carried out from January to June 2012, with the objective of identifying and stratifying the risk factors of pulmonary embolism, as well as the use of the prophylactic treatment during the hospital stay of the affected patients. The risk factors were determined and they were stratified in: low, moderate, high and very high, keeping in mind if they had indication or not of some type of prophylactic treatment, which was related to the hospital stay. It was verified that most of the affected patients had more than 2 risk factors associated, such as prolonged bedridding, age higher than 40 years, sepsis and certain comorbidity type, that allowed to classify them as high or very high risk cases of pulmonary embolism; however, prophylactic treatment was indicated just in half of them.


REFERENCES

  1. Goderich RR, Smith Smith VV, Paz Presilla E, Losada Gómez J, Serret Rodríguez B, Llamos Sierra N, et al. Temas de Medicina Interna. 4ed. La Habana: Editorial Ciencias Médicas, 2002; t1. p. 449-56.

  2. Calcines Sánchez E, Primellez Cruz D, Lima Guerra E, Molina Pérez J, Machado Varea A, Rufín Arregoitia A. Trombolisis en tromboembolismo pulmonar postoperatorio. Presentación de caso. Rev Med Electrón. 2010 [citado 9 May 2012];32(5). Disponible en: http://scielo.sld.cu/scielo.php?pid=S1684- 18242010000500012&script=sci_arttext

  3. Nazareno de la Fuente MC. Tromboembolismo pulmonar. Prevención o profilaxis. Fundación Europea de Enseñanza en Anestesiología. Andalucía: FORCONA. 2003.

  4. Fajes Alfonso AP, Herrera Pérez JL, Valdés García L, Novoa Puerto N, Fajes Alfonso JM. Tratamiento preventivo del tromboembolismo pulmonar. [citado 9 May 2012]. Disponible en:http://indexmedico.com/publicaciones/ indexmed_ journal/edicion9/tromboembolismo/fajes_alfonso.htm

  5. Burón Fernández MR, Pintor Holguin E, Minguez García P. Tromboembolismo pulmonar en pacientes hospitalizados entre 1994-2000. An Med Interna. 2006;23(7):317-20.

  6. De Franciscis S, Battista Agus G, Bisacci R, Botta G, Gasbarro V, Domanin M, et al. Guías de práctica clínica para el manejo del tromboembolismo en Italia: encuesta nacional. Anales de Cirugía Vascular. 2008;22(3):347-56.

  7. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation. 2004;110(24 Suppl 1):IV4-12.

  8. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S- 400S.

  9. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145-55.

  10. Tapson VF, Decousus H, Pini M, Chong BH, Froehlich JB, Monreal M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest. 2007;132(3):936-45.

  11. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–94.

  12. Gallardo Jiménez P, Guijarro Merino R, Vallejo Herrera V, Sánchez Morales D, Villalobo Sánchez A, Perelló González-Moreno JI, et al. Riesgo de enfermedad tromboembólica en pacientes hospitalizados no quirúrgicos. Grado de acuerdo entre la guía PRETEMED y las recomendaciones de la VIII conferencia del American College of Chest Physicians. Medicina Clínica. 2012;139(11):467-72.

  13. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparin and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ. 1994;309(6950):299-304.

  14. Barreras González I, Pila Pérez R, Guerra Rodríguez C, Paulino Basulto M. Incidencia por tromboembolismo pulmonar en el hospital “Manuel Ascunce Domenech”. Archivo Médico de Camagüey. 2002 [citado 7 Ago 2011];6(supl 3). Disponible en: http://www.amc.sld.cu/amc/2002/v6supl3/549.htm

  15. Hernández J, Dennis RJ, Londoño D, Gil JF. Evaluación de concordancia entre estrategias de profilaxis de tromboembolismo venoso en paciente médico en un hospital universitario, Bogotá, D.C. 2007-2008. Acta Médica Colombiana.2009; 34(1):4-10.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MediSan. 2013;17